Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193948 | SCV000247985 | pathogenic | Rett syndrome | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Centre for Population Genomics, |
RCV000193948 | SCV004808765 | pathogenic | Rett syndrome | 2024-03-15 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant has been identified as a de novo occurrence in an individual with Rett syndrome without confirmation of paternity and maternity (PM6). PMID 31178897. This variant is absent from gnomAD (PM2_Supporting). |
Al Jalila Children’s Genomics Center, |
RCV000193948 | SCV005420670 | likely pathogenic | Rett syndrome | 2024-10-04 | criteria provided, single submitter | research | PVS1,PM2 |
Rett |
RCV000133199 | SCV000188197 | pathogenic | not provided | 2011-02-15 | no assertion criteria provided | curation | |
Biochemistry Laboratory of CDMU, |
RCV000193948 | SCV000899198 | pathogenic | Rett syndrome | no assertion criteria provided | case-control |